Merck
Trade Merck 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MRK
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other.
MRK Key Statistics
Stock Snapshot
As of today, Merck(MRK) shares are valued at $109.45. The company's market cap stands at 271.86B, with a P/E ratio of 14.40 and a dividend yield of 3.0%.
As of 2026-01-20, Merck(MRK) stock has fluctuated between $106.93 and $109.64. The current price stands at $109.45, placing the stock +2.4% above today's low and -0.2% off the high.
The Merck(MRK)'s current trading volume is 14.95M, compared to an average daily volume of 13.66M.
In the last year, Merck(MRK) shares hit a 52-week high of $112.90 and a 52-week low of $73.31.
In the last year, Merck(MRK) shares hit a 52-week high of $112.90 and a 52-week low of $73.31.
MRK News
Moderna Inc. (NASDAQ:MRNA) and Merck & Co. Inc. (NYSE:MRK) on Tuesday shared median five-year follow-up data from the Phase 2b KEYNOTE-942/mRNA-4157-P201 study...
TD Cowen analyst Steve Scala raised the firm’s price target on Merck (MRK) to $120 from $100 and keeps a Hold rating on the shares. The firm said Merck is a gre...
Moderna (MRNA) and Merck (MRK), known as MSD outside of the United States and Canada, announced median five-year follow-up data from the Phase 2b Keynote-942/mR...
Analyst ratings
55%
of 29 ratingsMore MRK News
TD Cowen analyst Steve Scala has assigned their neutral stance on MRK stock, giving a Hold rating on January 13. Claim 50% Off TipRanks Premium Unlock hedge fun...
Guardant Health (GH) announced a multi-year collaboration with Merck (MRK), known as MSD outside the United States and Canada, to support the development and co...
In recent days, Illumina announced the launch of its Billion Cell Atlas, a large-scale CRISPR-based single-cell dataset built with founding participants includi...
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash f...
If you are wondering whether Merck’s current share price lines up with its underlying value, you are not alone. This article is built to help you frame that que...
Advertisement Merck stock reaction and recent return profile Merck (MRK) has drawn investor attention after a stretch of mixed short term performance, with a...
At the JPMorgan Healthcare Conference, biotechs and Big Pharma signaled they’re primed for M&A this year, after a big year for deals in 2025. Revolution Medici...
